Another all time low $0.96….

Quote

anonymous

Guest
Now at risk for delisting from NASDAQ due to price < $1.00. Your market cap of $12m is that of a penny stock. Cash on hand is burning, sales are lagging, cost saving measures not enough. Your upcoming quarterly result will likely be disappointing , and still taking another hit.. you May be at $0.50 by Memorial Day.
 








anonymous said:
Now at risk for delisting from NASDAQ due to price < $1.00. Your market cap of $12m is that of a penny stock. Cash on hand is burning, sales are lagging, cost saving measures not enough. Your upcoming quarterly result will likely be disappointing , and still taking another hit.. you May be at $0.50 by Memorial Day.
Click to expand...
Time for a reverse split. Rebound is coming. The Covid delayed it.
 








anonymous said:
Now at risk for delisting from NASDAQ due to price < $1.00. Your market cap of $12m is that of a penny stock.
Click to expand...

Delisting process takes some time. Time ACOR does not have. So not a real concern at this point,

$4.7M payment coming up for terminating Ardsley lease early. This can not be paid in shares so will take a good percentage of cash on hand.

CEO and COO raking in ~$2 million a year combined, 'running' a company with $12M Market Cap. This is near theft and further decimates cash on hand each month.

Upcoming interest payment will need to be paid in shares valued at about $1.00 each. So 6 million + shares will be issued, for a company with about 13 million shares outstanding currently. So close to 50% dilution in one fell swoop (and likely the main driver behind recent 50% share price drop....math is fun!!!). Process will repeat in 6 months, if ACOR makes it that long.

Nothing left to sell off to add cash to balance sheet to continue to pay employees, and no prospects whatsoever for obtaining additional capital from outside sources.

This company's slow death is picking up speed. There will be no merger. Anyone who wants anything ACOR has will be able to pick it up cheap when company dissolves and not have to deal with poison pill of keeping Acorda employees on payroll and paying RC and LS's salaries and benefits for two years.
 




anonymous said:
Delisting process takes some time. Time ACOR does not have. So not a real concern at this point,

$4.7M payment coming up for terminating Ardsley lease early. This can not be paid in shares so will take a good percentage of cash on hand.

CEO and COO raking in ~$2 million a year combined, 'running' a company with $12M Market Cap. This is near theft and further decimates cash on hand each month.

Upcoming interest payment will need to be paid in shares valued at about $1.00 each. So 6 million + shares will be issued, for a company with about 13 million shares outstanding currently. So close to 50% dilution in one fell swoop (and likely the main driver behind recent 50% share price drop....math is fun!!!). Process will repeat in 6 months, if ACOR makes it that long.

Nothing left to sell off to add cash to balance sheet to continue to pay employees, and no prospects whatsoever for obtaining additional capital from outside sources.

This company's slow death is picking up speed. There will be no merger. Anyone who wants anything ACOR has will be able to pick it up cheap when company dissolves and not have to deal with poison pill of keeping Acorda employees on payroll and paying RC and LS's salaries and benefits for two years.
Click to expand...
 




anonymous said:
Delisting process takes some time. Time ACOR does not have. So not a real concern at this point,

$4.7M payment coming up for terminating Ardsley lease early. This can not be paid in shares so will take a good percentage of cash on hand.

CEO and COO raking in ~$2 million a year combined, 'running' a company with $12M Market Cap. This is near theft and further decimates cash on hand each month.

Upcoming interest payment will need to be paid in shares valued at about $1.00 each. So 6 million + shares will be issued, for a company with about 13 million shares outstanding currently. So close to 50% dilution in one fell swoop (and likely the main driver behind recent 50% share price drop....math is fun!!!). Process will repeat in 6 months, if ACOR makes it that long.

Nothing left to sell off to add cash to balance sheet to continue to pay employees, and no prospects whatsoever for obtaining additional capital from outside sources.

This company's slow death is picking up speed. There will be no merger. Anyone who wants anything ACOR has will be able to pick it up cheap when company dissolves and not have to deal with poison pill of keeping Acorda employees on payroll and paying RC and LS's salaries and benefits for two years.
Click to expand...

Free Falling…. $0.91
 




anonymous said:
Delisting process takes some time. Time ACOR does not have. So not a real concern at this point,

$4.7M payment coming up for terminating Ardsley lease early. This can not be paid in shares so will take a good percentage of cash on hand.

CEO and COO raking in ~$2 million a year combined, 'running' a company with $12M Market Cap. This is near theft and further decimates cash on hand each month.

Upcoming interest payment will need to be paid in shares valued at about $1.00 each. So 6 million + shares will be issued, for a company with about 13 million shares outstanding currently. So close to 50% dilution in one fell swoop (and likely the main driver behind recent 50% share price drop....math is fun!!!). Process will repeat in 6 months, if ACOR makes it that long.

Nothing left to sell off to add cash to balance sheet to continue to pay employees, and no prospects whatsoever for obtaining additional capital from outside sources.

This company's slow death is picking up speed. There will be no merger. Anyone who wants anything ACOR has will be able to pick it up cheap when company dissolves and not have to deal with poison pill of keeping Acorda employees on payroll and paying RC and LS's salaries and benefits for two years.
Click to expand...

From the Pro: believe top two have golden parachutes so will land softly if Acorda folds. Question: are the rank n filers unionized?

Maybe best hope is a federal handout (ARA funds?) to maintain critical Inbrija meds and move to even smaller offices to buy more time. Also reduce variable costs (salaries and benefits), although painfull. Then slowly rebuild through the Rebound.
 




anonymous said:
From the Pro: believe top two have golden parachutes so will land softly if Acorda folds. Question: are the rank n filers unionized?

Maybe best hope is a federal handout (ARA funds?) to maintain critical Inbrija meds and move to even smaller offices to buy more time. Also reduce variable costs (salaries and benefits), although painfull. Then slowly rebuild through the Rebound.
Click to expand...

You are an idiot, PR MONKEY! Nothing you have posted for 3 years has made a bit of sense, and you continue to post nonsense.

Acorda is not the sole provider of levadopa.....there is no reason for the government or anyone else to buy more time for Acorda. There will be no rebound...just a question of how long can RC, LS and the remaining 40 employees continue to collect checks until the cash runs out.
 












Now less than $0.90/ share....less than $12 million market cap.

Adjusting for reverse split, this is less than 15 cents/share.

Earnings call should be VERY interesting Wednesday.
 








Low of 81.53 cents per share today. Simply pathetic. I guess the BOD still refuses to do something about senior management (other than promote them).

Little PR MONKEY, it would probably be a good time for some positive moral boosting...it's about all that is left.
 












Maybe best hope is a federal handout (ARA funds?) to maintain critical Inbrija meds and move to even smaller offices to buy more time. Also reduce variable costs (salaries and benefits), although painful. Then slowly rebuild through the Rebound

Ok to post
 
















Top Bottom
Back
Quote